Complex surgical wounds require more than routine closure. They may involve extensive tissue disruption, compromised blood flow, dead space, implanted hardware, revision surgery, traumatic injury, or patient factors that increase the risk of delayed healing.
In these situations, surgical teams often use a coordinated strategy that addresses wound-bed preparation, contamination control, moisture balance, tissue support, closure technique, and postoperative monitoring.
Activated collagen technology can serve as an adjunct within that broader strategy. CellerateRX® Surgical Powder from Sanara MedTech is a Type I bovine hydrolyzed collagen product intended for the management of surgical wounds, traumatic wounds, partial- and full-thickness wounds, and first- and second-degree burns. It does not replace clinical judgment, infection-prevention measures, appropriate wound preparation, surgical closure, or treatment of underlying health conditions.
What Makes a Surgical Wound Complex?
A surgical wound may be considered complex when local or systemic conditions make predictable healing more difficult. These conditions may include:
- Previous surgeries or revision procedures
- Large incisions or significant tissue loss
- Compromised vascular supply
- Excessive tension across the surgical site
- Contamination or elevated infection risk
- Diabetes
- Obesity
- Smoking
- Immunosuppression
- Malnutrition
- Implanted devices or surgical hardware
Normal wound healing occurs through four overlapping phases: hemostasis, inflammation, proliferation, and remodeling. Infection, insufficient oxygenation, impaired immune response, wound separation, and other complications can interrupt this progression.
Because complex surgical wounds often involve several risk factors at the same time, effective management typically depends on addressing multiple barriers to healing rather than relying on one product or technique.
Why Is Collagen Important in Wound Healing?
Collagen is a major structural component of the extracellular matrix and plays an important role throughout the wound-healing process. It contributes to the framework that supports cellular activity, tissue organization, granulation tissue development, and wound remodeling. Fibroblasts also produce collagen and other extracellular-matrix components as new tissue develops.
Native collagen is composed of relatively large, insoluble molecules. Hydrolyzed collagen has been broken down into smaller peptides and amino-acid fragments.
Sanara MedTech describes CellerateRX Surgical Powder as hydrolyzed fragments of Type I bovine collagen that are approximately one-hundredth the size of native collagen. This hydrolyzed format allows collagen fragments to be delivered directly to the wound bed without first requiring the body to break down a larger native-collagen structure.
What Is Activated Collagen Technology?
Activated collagen is Sanara MedTech’s terminology associated with its hydrolyzed collagen technology. Hydrolysis breaks collagen into smaller fragments that can be placed directly into the surgical wound environment.
Activated collagen technology is intended to support the wound environment. It should not be described as independently healing a wound or replacing accepted surgical practices.
In appropriate cases, hydrolyzed collagen powder may help distribute collagen fragments across an irregular wound bed, including tissue planes and areas that may be difficult to address with a sheet-form material.
How Can Activated Collagen Support a Complex Surgical Wound?
CellerateRX Surgical Powder offers several practical characteristics for surgical teams:
- It can conform to the contours of a surgical wound.
- It provides hydrolyzed Type I bovine collagen directly to the wound bed.
- It is sterilized and packaged for use in the operating room.
- It can be incorporated into an established surgical wound-management protocol.
- Sanara MedTech identifies it as compatible with negative pressure wound therapy.
- It is available in multiple quantities to accommodate different procedural needs.
These characteristics may be relevant when a wound includes uneven surfaces, tissue planes, extensive surgical exposure, or areas requiring broad contact with an adjunctive material.
Product selection and application should always reflect the type of procedure, condition of the wound, patient risk factors, current instructions for use, facility protocols, and the clinician’s independent judgment.
Where Does CellerateRX Surgical Powder Fit Into Surgical Care?
CellerateRX Surgical Powder is positioned as an adjunct to surgical wound management.
Sanara MedTech’s general application guidance describes three primary steps:
- Prepare the surgical wound site.
- Apply CellerateRX Surgical Powder to the wound.
- Cover or close the surgical wound according to the clinician’s protocol.
This sequence should not be interpreted as a complete wound-care plan. Depending on the patient and procedure, complex surgical wound management may also involve:
- Irrigation and wound cleansing
- Debridement when clinically indicated
- Management of bacterial burden
- Hemostasis
- Elimination or management of dead space
- Reduction of tension across the incision
- Drain placement
- Vascular assessment
- Glycemic management
- Nutritional support
- Pressure management
- Negative pressure wound therapy
- Ongoing postoperative monitoring
The appropriate use of any advanced surgical product begins with identifying the specific factors that may interfere with healing. Activated collagen may address one part of the wound environment while the care team manages the biological, mechanical, and patient-related factors affecting the case.
What Does the Clinical Evidence Show?
Clinical evidence regarding hydrolyzed collagen in surgery continues to develop.
Sanara MedTech reported findings from a retrospective study involving 5,335 elective surgical patients across multiple specialties. The analysis found an association between CellerateRX use and lower surgical-site infection rates, including a reported 59% overall reduction.
Because the study was retrospective and partially funded through a grant from a Sanara MedTech subsidiary, the results should be interpreted within those limitations. The findings do not establish that the product alone caused the difference in infection rates.
Other procedure-specific retrospective research has also emphasized the need for larger, controlled studies before broad conclusions are made regarding hydrolyzed collagen and postoperative wound complications.
Observational findings can help guide additional research, but clinical decisions should remain grounded in the complete evidence base, current product labeling, institutional protocols, the surgeon’s experience, and the needs of the individual patient.
Why Is a Team-Based Approach Important?
Complex surgical wound management may involve surgeons, operating-room nurses, wound-care specialists, infectious-disease clinicians, vascular specialists, nutrition professionals, home-health providers, and post-acute care teams.
Coordination becomes especially important when a patient transitions from the operating room to inpatient care, outpatient follow-up, home health, or a skilled nursing facility.
The care plan should establish:
- How the wound will be evaluated
- How often dressings will be changed
- Who is responsible for follow-up
- Which findings require escalation
- How adjunctive therapies will be managed
- How patient risk factors will be addressed
Increasing drainage, unexpected pain, redness, wound separation, fever, odor, or tissue deterioration require prompt clinical evaluation. Activated collagen technology should be viewed as one component of this care continuum rather than as an isolated intervention.
